The first stop for professional medicines advice

Ambrisentan

Published
Topics: AmbrisentanCardiovascular system disordersNew Medicines · NHS England commissioned new medicinesPatent expiriesPre-registration new medicines (UK/EU)Safety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Medicine Compliance Aid Stability
    1. Volibris · GlaxoSmithKline UK
  3. Lactation Safety Information

dm+d

427735003

Medicine Compliance Aid Stability

VolibrisGlaxoSmithKline UK

GlaxoSmithKline UK
Volibris
Tablets f/c 5mg, 10mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage
25 October 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

No
Sildenafil
No published evidence of safety
Although low levels anticipated in milk due to the drug’s properties, serious adverse effects have been reported in adults
Safety in Lactation: Drugs for hypertension
16 January 2017
Bibliography